Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Accepts healthy volunteers

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

ClinicalTrials.gov ID: NCT05468736

Public ClinicalTrials.gov record NCT05468736. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 5:37 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3 Age De-escalating Study to Evaluate the Safety and Immunogenicity of a SARS-CoV-2 Recombinant Spike Protein Vaccine (SARS-CoV-2 rS) With Matrix-M™ Adjuvant in Children 6 Months to < 12 Years of Age

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a Phase 2/3 randomized, observer-blinded, placebo-controlled, age de-escalation trial to evaluate the safety and immunogenicity of 2 primary doses of SARS-CoV-2 rS with Matrix-M™ adjuvant (NVX-CoV2373) given 21 days apart and NVX CoV2373 or a variant-based vaccine given as a booster dose or at crossover in pediatric participants (3 age cohorts; 6 to \< 12 years, 2 to \< 6 years, and 6 to \< 24 months of age). Each age cohort will be conducted in 2 parts starting with the oldest age cohort (6 to \< 12 years of age).

Study identification

NCT ID
NCT05468736
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Novavax
Industry
Enrollment
3,600 participants

Conditions and interventions

Conditions

Interventions

Biological · Other

Eligibility (public fields only)

Age range
6 Months to 11 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 22, 2022 (Actual)
Primary completion
Jan 16, 2024 (Actual)
Completion
Oct 25, 2025 (Actual)
Last update posted
May 22, 2026

2022 – 2025

United States locations

U.S. sites
47
U.S. states
19
U.S. cities
44
Facility City State ZIP Site status
Preferred Research Partners, Inc. Little Rock Arkansas 72211 —
Advanced Research Center Anaheim California 92805 —
Coast Clinical Research, LLC Bellflower California 90706 —
Apex Research Group Fair Oaks California 95628 —
Ark Clinical Research Long Beach California 90815 —
Orange County Research Institute Ontario California 91762 —
California Research Foundation San Diego California 92123 —
Clinical Research of California Walnut Creek California 94598 —
Imagine Research of Palm Beach County Boynton Beach Florida 33435 —
Palm Harbor Dermatology PA Brandon Florida 33511 —
Westside Center for Clinical Research Jacksonville Florida 32205 —
Cordova Research Institute, LLC Miami Florida 33155 —
ARS-Nona Pediatric Center Orlando Florida 32829 —
Morehouse School of Medicine Atlanta Georgia 30310 —
Tekton Research - Atlanta Chamblee Georgia 30341 —
Leavitt Clinical Research Idaho Falls Idaho 83404 —
Michael W. Simon, M.D., PSC Lexington Kentucky 40517 —
Bluegrass Clinical Research, Inc./All Children Pediatrics Louisville Kentucky 40243 —
Velocity Clinical Research - Covington, LA Covington Louisiana 70433 —
Velocity Clinical Research - Covington Covington Louisiana 70433 —
Velocity Clinical Research - Lafayette LA Lafayette Louisiana 70508 —
Craig A. Spiegel, M.D. Bridgeton Missouri 63044 —
Boeson Research Missoula Montana 59804 —
Meridian Clinical Research Lincoln Nebraska 68510 —
Be Well Clinical Studies, LLC Lincoln Nebraska 68516 —
Corning Center for Clinical Research Horseheads New York 14845 —
Velocity Clinical Research Beachwood Ohio 44122 —
Dayton Clinical Research Dayton Ohio 45409 —
Senders Pediatrics South Euclid Ohio 44121 —
Lynn Institute of Tulsa Tulsa Oklahoma 74135 —
Velocity Clinical Research Grants Pass Grants Pass Oregon 97527 —
Tribe Clinical Research Greenville South Carolina 29607 —
WR - ClinSearch, LLC Chattanooga Tennessee 37421 —
Clinical Research Associates, Inc. Nashville Tennessee 37203 —
Tekton Research Beaumont Beaumont Texas 77706 —
PanAmerican Clinical Research Brownsville Texas 78520 —
South Texas Clinical Research Corpus Christi Texas 78404 —
Bay Colony Pediatrics Dickinson Texas 77539 —
Trio Clinical Trials Houston Texas 77008 —
Mercury Clinical Research Houston Texas 77087 —
Research Your Health Plano Texas 75093 —
Mercury Clinical Research - Pediatric Center Richmond Texas 77469 —
Tekton Research San Antonio Texas 78244 —
Alliance for Multispecialty Research Layton Utah 84041 —
Alliance for Multispecialty Research c/o Wee Care Pediatrics - Roy Roy Utah 84067 —
Velocity Clinical Research - West Jordan West Jordan Utah 84088 —
Clinical Research Partners, LLC Richmond Virginia 23226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 47 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05468736, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 22, 2026 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05468736 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →